| Reproductive Biology and Fertility | Lifetime | 86 | US 35 | 99.59 |
| Ovarian function and disorders | Lifetime | 93 | US 27 | 99.41 |
| Reproductive Health and Technologies | Lifetime | 75 | US 33 | 99.02 |
| Growth Hormone and Insulin-like Growth Factors | Lifetime | 159 | US 73 | 98.94 |
| Reproductive System and Pregnancy | Lifetime | 166 | US 71 | 98.80 |
| Reproductive Physiology in Livestock | Lifetime | 231 | US 111 | 98.88 |
| Estrogen and related hormone effects | Lifetime | 386 | US 242 | 98.52 |
| Assisted Reproductive Technology and Twin Pregnancy | Lifetime | 217 | US 80 | 98.58 |
| Biomedical Ethics and Regulation | Lifetime | 78 | US 47 | 96.89 |
| Diversity and Career in Medicine | Lifetime | 271 | US 202 | 95.94 |
| Healthcare Policy and Management | Lifetime | 884 | US 603 | 96.29 |
| Hormonal and reproductive studies | Lifetime | 821 | US 383 | 96.52 |
| Medical Education and Admissions | Lifetime | 283 | US 170 | 93.71 |
| Hypothalamic control of reproductive hormones | Lifetime | 635 | US 327 | 94.10 |
| Legal Systems and Judicial Processes | Lifetime | 381 | US 334 | 92.98 |
| Global Health Workforce Issues | Lifetime | 873 | US 331 | 92.11 |
| Ethics and Legal Issues in Pediatric Healthcare | Lifetime | 609 | US 323 | 90.43 |
| Reproductive Health and Contraception | Lifetime | 970 | US 531 | 91.19 |
| Ethics in Clinical Research | Lifetime | 981 | US 524 | 89.33 |
| Pharmaceutical industry and healthcare | Lifetime | 629 | US 359 | 84.74 |
| Neuroethics, Human Enhancement, Biomedical Innovations | Lifetime | 448 | US 156 | 79.95 |
| Science, Research, and Medicine | Lifetime | 482 | US 239 | 76.42 |
| Occupational and Professional Licensing Regulation | Lifetime | 159 | US 112 | 60.28 |
| Reproductive Health and Technologies | 2021-2025 | 24 | US 11 | 98.29 |
| Biomedical Ethics and Regulation | 2021-2025 | 11 | US 6 | 96.36 |
| Global Health Workforce Issues | 2021-2025 | 41 | US 11 | 96.48 |
| Diversity and Career in Medicine | 2021-2025 | 95 | US 77 | 96.03 |
| Assisted Reproductive Technology and Twin Pregnancy | 2021-2025 | 86 | US 21 | 96.33 |
| Healthcare Policy and Management | 2021-2025 | 126 | US 101 | 95.09 |
| Reproductive Health and Contraception | 2021-2025 | 101 | US 67 | 93.95 |
| Pharmaceutical Economics and Policy | 2021-2025 | 120 | US 48 | 92.35 |
| CRISPR and Genetic Engineering | 2021-2025 | 569 | US 173 | 91.63 |
| Legal Systems and Judicial Processes | 2021-2025 | 8 | US 7 | 89.39 |
| Reproductive Biology and Fertility | 2021-2025 | 835 | US 132 | 90.30 |
| Prenatal Screening and Diagnostics | 2021-2025 | 420 | US 120 | 89.03 |
| Pregnancy and Medication Impact | 2021-2025 | 292 | US 100 | 87.71 |
| Disaster Response and Management | 2021-2025 | 388 | US 102 | 84.56 |
| Ethics and Legal Issues in Pediatric Healthcare | 2021-2025 | 158 | US 80 | 81.78 |
| Primary Care and Health Outcomes | 2021-2025 | 707 | US 371 | 81.43 |
| Healthcare cost, quality, practices | 2021-2025 | 473 | US 202 | 80.53 |
| Neuroethics, Human Enhancement, Biomedical Innovations | 2021-2025 | 68 | US 13 | 81.76 |
| Pharmaceutical industry and healthcare | 2021-2025 | 84 | US 38 | 79.60 |
| Medical Education and Admissions | 2021-2025 | 252 | US 178 | 78.54 |
| Public Health Policies and Education | 2021-2025 | 388 | US 240 | 62.77 |
| Medical Malpractice and Liability Issues | 2021-2025 | 743 | US 220 | 63.18 |
| Demographic Trends and Gender Preferences | 2021-2025 | 459 | US 96 | 52.45 |
